These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30992017)

  • 21. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
    Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
    Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
    Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis.
    Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z
    Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer.
    Zhang Y; Pavlov A; Malik S; Chen H; Kim N; Li Z; Zhang X; DePamphilis ML; Roeder RG; Ge H
    PLoS One; 2020; 15(3):e0230670. PubMed ID: 32231397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL.
    Lee HY; Cha J; Kim SK; Park JH; Song KH; Kim P; Kim MY
    Mol Cancer Res; 2019 Feb; 17(2):544-554. PubMed ID: 30266755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
    Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
    J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
    Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
    BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pro-metastasis effect of circANKS1B in breast cancer.
    Zeng K; He B; Yang BB; Xu T; Chen X; Xu M; Liu X; Sun H; Pan Y; Wang S
    Mol Cancer; 2018 Nov; 17(1):160. PubMed ID: 30454010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.
    Kim JM; Kim K; Schmidt T; Punj V; Tucker H; Rice JC; Ulmer TS; An W
    Nucleic Acids Res; 2015 Oct; 43(18):8868-83. PubMed ID: 26350217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
    Wang H; Tan Z; Hu H; Liu H; Wu T; Zheng C; Wang X; Luo Z; Wang J; Liu S; Lu Z; Tu J
    BMC Cancer; 2019 Jul; 19(1):738. PubMed ID: 31351450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.